Brett Wingeier

CEO and co-founder of Magnus Medical. BME PhD, neurotech and data wrangler. Building stuff for your brain, stuff that works. Cyclist, climber, father of two.

[Brett Wingeier @wingeier]

Glad to finally share: so proud to be working with the @magnusmed team on breakthrough #neuromodulation treatment for #depression. Together we can help restore and sustain #mentalhealth.

[Magnus Medical @magnus_medical]

Proud to share that the FDA granted Breakthrough Device Designation for our individualized, non-invasive, investigational #neuromodulation technology for people with major #depression. https://t.co/rI4h8nuGhH
#innovation #fMRI #targeted #brainhealth

[Brett Wingeier @wingeier]

I'll withhold the sarcasm and schadenfreude, because empathy for real people who lost money. Instead I'll just share a great piece: https://t.co/0aEHfNelwY

[Brett Wingeier @wingeier]

Check out the latest on SAINT - so very proud to be helping bring this technology to the world!

[Magnus Medical @magnus_medical]

Very informative story on the @Todayshow featuring Dr. @NolanRyWilliams, @Stanford_BSL, talking about SAINT, a promising new, investigational treatment for major #depression. Powerful stories shared by two students treated by SAINT.
https://t.co/w1LT7zkRux

[Magnus Medical @magnus_medical]

Very informative story on the @Todayshow featuring Dr. @NolanRyWilliams, @Stanford_BSL, talking about SAINT, a promising new, investigational treatment for major #depression. Powerful stories shared by two students treated by SAINT.
https://t.co/w1LT7zkRux

[Brett Wingeier @wingeier]

Nice talk from @AlikWidge at @APAPsychiatric meeting just now on deep #brain stimulation in #psychiatric disease. Next gen of clinical trials should yield huge advances!

[Nolan Williams @NolanRyWilliams]

Many thanks to @CBSSunday for a great interview. I would also like to thank the team that have worked so very hard to make SAINT a reality (@EleanorJCole, @BrandonBentzley, @Stanford_BSL). @standfordmed @Stanford @StanfordPSY

https://t.co/XGMpOaFg5R

[Brett Wingeier @wingeier]

Congratulations to @NolanRyWilliams and the team at @Stanford_BSL for their breakthrough work on #depression which appeared on @CBSSunday today. And honored to be part of @MagnusMed entrusted with bringing it to the world. #mentalhealth #brainhealth https://t.co/TPwkHl67iR

[Brett Wingeier @wingeier]

Thanks, @neurotechwriter, for including @MagnusMed in the Neurotech Leaders Forum next week! Looking forward to it, and in particular spending time talking about the need and opportunities for #neuromodulation in #mentalhealth with great folks advancing #neurotech.

[James Cavuoto @neurotechwriter]

The 20th Anniversary Neurotech Leaders Forum takes place next week! https://t.co/DtGIEOYeMM

[James Cavuoto @neurotechwriter]

The 20th Anniversary Neurotech Leaders Forum takes place next week! https://t.co/DtGIEOYeMM

[Nolan Williams @NolanRyWilliams]

Please RT!

[Brett Wingeier @wingeier]

Well, I can't figure out a way to tweet this without dropping an ultra-high-res photo of my face into everyone's feeds. But nonetheless - thanks @SFBIZronleuty for a great piece on @magnusmed and our breakthrough #neuromodulation tech for #depression! https://t.co/WkEwhOR6Bc

[MassDevice @MassDevice]

#MagnusMedical announced today that it received FDA breakthrough device designation for its #Neurostimulation technology and raised $25 million.

MORE ON THIS HERE: https://t.co/TXb5VtygHN

#MDD #Depression #MentalHealth #Neuro @wingeier @mAGNUSMEDICAL @MagnusHealth

[Brett Wingeier @wingeier]

@SJohannesMD @magnusmed Thanks, @SJohannesMD, and 100% agreed. ED boarding such an enormous and important problem, and we finally might be able to do something about it.

[Patrick J. Kennedy @PJK4brainhealth]

We’ve made great strides in treating diabetes & heart disease, but the same can’t be said for illnesses of the brain—like major depression—which affects 17.3 million U.S. adults. This news about SAINT technology holds promise for so many, and couldn’t have come at a better time.

[Carly A. Lasagna @Carly_Lasagna]

Excellent work from folks at Stanford. Can’t stress enough the importance of fMRI/MRI-guided individualized target localization in #TMS. This is such an interesting method — using the dlPFC location with functional connectivity most anti correlated with sgACC during rest.

[Brett Wingeier @wingeier]

Thanks to @ConorHale and @FierceMedTech / @FierceBiotech for your great coverage of @magnusmed's technology for treatment-resistant #depression! https://t.co/3gd6RNkjQ8

[Brain Stimulation Lab @Stanford_BSL]

Additionally, no severe adverse events occurred during the trial! The only side effect that approached statistical significance in the active treatment group over the sham treatment group was headache.

[Brain Stimulation Lab @Stanford_BSL]

Encouraging data in @APAPubJournals from our double-blinded RCT evaluating Stanford Neuromodulation Therapy (SAINT) for treatment-resistant #depression. After 5 days, 79% in the active group achieved remission from depression compared to 13% in sham
https://t.co/cTOMIO1W2l

[Brett Wingeier @wingeier]

Great news breaking courtesy of @Gizmodo tonight - long-awaited randomized clinical trial supports remarkable effectiveness of rapid, non-invasive #neuromodulation for treatment-resistant #depression. https://t.co/tCrJj9YTJq

[Brett Wingeier @wingeier]

Whenever I am asked to find something in a drawer full of kids' clothes, it feels exactly like needing to find one particular snake in a drawer full of identical snakes